GConferenceGridThe Conference Catalogue · Vol. 2027Folio № 732D7D
Of the Field

Festival of Biologics USA 2027

T

he Festival of Biologics USA is America’s most comprehensive biologics event, covering the entire industry from antibody therapies, cell and gene therapies, immunotherapies, to biosimilars. It brings together 2,000+ attendees from pharma, biotech, start-ups, academia, regulators and investors for two days of presentations, panels, networking, and workshops.…

Visit the official siteRegister
41Voices
31Underwriters
1Exhibitors
8On the bill · sessions
57Companies · in total
§I

The Voices

Programmed at Festival, in alphabetical order.
Aamer Ejaz
Group Vice President, Carrier Business (PTCL & Ufone) · Pakistan Telecommunication Company Limited (PTCL)
Afifa Dean
Head, Media Management · Telekom Malaysia
Anne Kerber
Senior Vice President, Head Cell Therapy Development · Bristol Myers Squibb
Ayomal Gunasekera
Chief of Group Customer Experience · Dialog Axiata PLC
Brajesh Bhagat
Global Category Manager - Network Services · Telenor Procurement Company
Chris Mason
Professor of Cell and Gene Therapy · UCL
Danny Han Seng Foong
SVP, Head of Commercial Portfolio & Strategy Execution · True Corporation
Dinie Rahimi Che Ayob
Cloud Communications Sales & Business Development Director APAC · Deutsche Telekom T Wholesale
Emanuela Lacana
Deputy Director, Office of Therapeutic Biologics and Biosimilars/ OND/ CDER · FDA
Eugene Zhukovsy
Vice President and Site Head of Biologics R&D · Orion Pharma
Faisal Ahmed
Digital Platforms & Engineering Director · Banglalink
Gaurav Hirani
General Manager — Cloud and AIOps · Jio
Gaya Byrne
Head of Service Operations & Customer Success · Telstra International
George Aprane
Managing Director, Asia · Deutsche Telekom
Gillian Woollett
Head of Regulatory Strategy & Policy · Samsung Bioepis
Isabell Remus
Global Head of Biosimilars · Sandoz
Jane Seagal
VP of Antibody Discovery · AlivaMab Discovery Services
Jay Mandrekar
Professor of Biostatistics & Neurology · Mayo Clinic
Jayson Ho
Regional Sales Director (ASEAN) · Orange Carriers Singapore
Jennifer Echevarria
Vice President of Enterprise Data and Strategic Services · Globe Telecom
Jerry Cacacho
Director - Global Corporate Sales · KDDI
Joe Chow
Head of Procurement and Supply Chain · Digital Nasional Berhad (DNB)

— and 19 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
AbbVie
AlivaMab Discovery Services
Amgen
Arscientia
Biogen
Bristol Myers Squibb
Diachi Sankyo
Exreprotein LLC
Fate Therapeutics
FDA
Fujifilm
Genentech
Genevation LTD
Gilead
Gritstone Bio
Icosagen
Immunogen
isla
Mayo Clinic
MSKCC
Novartis
Orion Pharma
Pfizer
Samsung Bioepis
Samsung Biologics
Sandoz
Sanofi
Tavotek Biotherapeutics
Terrapinn Pte Ltd
UCL
UCSD
§III

The Programme

Selected from 8 sessions on the bill.
  • Nov 18 11:40

    Ai-driven strategies for the next-gen cloud: Building the telecom playbook

    NETWORK
  • Nov 18 11:40

    AI in action — Personalising services and transforming customer experience

    CUSTOMER
  • Nov 18 11:40

    Infrastructure sharing models: Collaborating and competing

    THE TELCO BOARDROOM
  • Nov 18 12:00

    PANEL: From predicting problems to optimising outcomes and delivering dollars — is AI the answer?

    THE TELCO BOARDROOM
  • Nov 18 12:00

    PANEL: NaaS for telco operators in Asia: Cloud first, cloud only?

    NETWORK
  • Nov 18 12:00

    The Telco AI Trifecta – Enabling autonomous, customer-centric networks

    CUSTOMER
  • Nov 18 9:15

    Organiser’s Welcome

    Keynotes
  • Nov 18 9:30

    KEYNOTE PANEL: AI — faster, leaner, smarter... is the telco of tomorrow already today?

    Keynotes
Intermission
Part the Second · For the Buyer

What does it mean when 57 companies show up — and 13 bet on three roles at once?

57 companies. thirteen are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
13All threespeak · spons · exh
18Sponsoringsponsor only
1Exhibitingexhibitor only
25Speakingspeaker only

The Triple-Threat

FDA·AlivaMab Discovery Services·Bristol Myers Squibb·Fate Therapeutics·Genevation LTD·Immunogen·Mayo Clinic·MSKCC·Orion Pharma·Samsung Bioepis·Sandoz·Sanofi·UCL

02Fig. 02 — The Voices, by Seniority

78% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite410%
  • Founder / Owner12%
  • VP-level1024%
  • Director / Head of1741%
  • Manager / Lead25%
  • Other roles717%

Of 41 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01FDASp2V
  2. 02AlivaMab Discovery ServicesSp1V
  3. 03Bristol Myers SquibbSp1V
  4. 04Fate TherapeuticsSp1V
  5. 05Genevation LTDSp1V
  6. 06ImmunogenSp1V
  7. 07Mayo ClinicSp1V
  8. 08MSKCCSp1V
  9. 09Orion PharmaSp1V
  10. 10Samsung BioepisSp1V
  11. 11SandozSp1V
  12. 12SanofiSp1V
  13. 13UCLSp1V
  14. 14AbbVieSp
04Fig. 04 — By Tier
unspecified31
100% of 31
05Fig. 05 — The Missing · who's at peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

06Fig. 06 — Adjacent Convocations · by shared underwriters